Tokyo, Jan. 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060328) titled 'Efficacy of autologous and allogeneic hematopoietic cell transplantation in adults with extranodal NK/T-cell lymphoma: a systematic review and meta-analysis' on Jan. 11.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Jichi Medical University
Condition:
Condition - extranodal NK/T-cell lymphoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the efficacy of autologous and allogeneic hematopoietic stem cell transplantation for adult extranodal NK/T-cell lymphoma.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Adult patients with extranodal NK/T-cell lymphoma (ENKL).
2. Patients who underwent treatment with autologous or allogeneic hematopoietic stem cell transplantation.
Study design:
A comprehensive literature search will be conducted in PubMed and Embase according to the search strategy described below (see the "Other" section). No restrictions will be applied with respect to language, country of origin, publication date, study design (prospective or retrospective), single-center or multicenter setting, or registry-based studies. Eligible studies must include at least five patients with ENKL. If a study includes patients with other diseases, only data specific to ENKL patients will be extracted and analyzed.
Key exclusion criteria - 1.Duplicate publications
2.Conference proceedings
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 01 Month 11 Day
Anticipated trial start date - 2026 Year 01 Month 11 Day
Last follow-up date - 2028 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069006
Disclaimer: Curated by HT Syndication.
